Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Kewaunee Scientific (KEQU) Short-Term Debt issuances (2016 - 2026)

Kewaunee Scientific has reported Short-Term Debt issuances over the past 15 years, most recently at $11.4 million for Q1 2026.

  • Quarterly results put Short-Term Debt issuances at $11.4 million for Q1 2026, up 41.28% from a year ago — trailing twelve months through Jan 2026 was $16.1 million (down 85.13% YoY), and the annual figure for FY2025 was $73.5 million, down 50.37%.
  • Short-Term Debt issuances for Q1 2026 was $11.4 million at Kewaunee Scientific, up from $2.0 million in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for KEQU hit a ceiling of $40.6 million in Q3 2023 and a floor of $1.3 million in Q2 2025.
  • Median Short-Term Debt issuances over the past 5 years was $19.8 million (2022), compared with a mean of $20.5 million.
  • Biggest five-year swings in Short-Term Debt issuances: skyrocketed 816.2% in 2023 and later crashed 96.42% in 2025.
  • Kewaunee Scientific's Short-Term Debt issuances stood at $4.4 million in 2022, then skyrocketed by 769.31% to $38.5 million in 2023, then tumbled by 33.44% to $25.6 million in 2024, then crashed by 92.28% to $2.0 million in 2025, then skyrocketed by 476.4% to $11.4 million in 2026.
  • The last three reported values for Short-Term Debt issuances were $11.4 million (Q1 2026), $2.0 million (Q4 2025), and $1.4 million (Q3 2025) per Business Quant data.